These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 19563606)

  • 1. A critical analysis of current in vitro and in vivo angiogenesis assays.
    Staton CA; Reed MW; Brown NJ
    Int J Exp Pathol; 2009 Jun; 90(3):195-221. PubMed ID: 19563606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current methods for assaying angiogenesis in vitro and in vivo.
    Staton CA; Stribbling SM; Tazzyman S; Hughes R; Brown NJ; Lewis CE
    Int J Exp Pathol; 2004 Oct; 85(5):233-48. PubMed ID: 15379956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.
    Goodwin AM
    Microvasc Res; 2007; 74(2-3):172-83. PubMed ID: 17631914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?
    Shen FZ; Wang J; Liang J; Mu K; Hou JY; Wang YT
    Int J Exp Pathol; 2010 Feb; 91(1):10-6. PubMed ID: 20096070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust and Scalable Angiogenesis Assay of Perfused 3D Human iPSC-Derived Endothelium for Anti-Angiogenic Drug Screening.
    van Duinen V; Stam W; Mulder E; Famili F; Reijerkerk A; Vulto P; Hankemeier T; van Zonneveld AJ
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
    Seng WL; Eng K; Lee J; McGrath P
    Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
    Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
    As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
    Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis assays: a critical overview.
    Auerbach R; Lewis R; Shinners B; Kubai L; Akhtar N
    Clin Chem; 2003 Jan; 49(1):32-40. PubMed ID: 12507958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
    Pan SL; Guh JH; Peng CY; Wang SW; Chang YL; Cheng FC; Chang JH; Kuo SC; Lee FY; Teng CM
    J Pharmacol Exp Ther; 2005 Jul; 314(1):35-42. PubMed ID: 15784655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neridronate inhibits angiogenesis in vitro and in vivo.
    Ribatti D; Nico B; Mangieri D; Maruotti N; Longo V; Vacca A; Cantatore FP
    Clin Rheumatol; 2007 Jul; 26(7):1094-8. PubMed ID: 17106617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
    Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
    Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrotide: an endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo.
    Koehl GE; Geissler EK; Iacobelli M; Frei C; Burger V; Haffner S; Holler E; Andreesen R; Schlitt HJ; Eissner G
    Cancer Biol Ther; 2007 May; 6(5):686-90. PubMed ID: 17495522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
    Tufan AC; Satiroglu-Tufan NL
    Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
    Pisanti S; Borselli C; Oliviero O; Laezza C; Gazzerro P; Bifulco M
    J Cell Physiol; 2007 May; 211(2):495-503. PubMed ID: 17192847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative ELISA-based co-culture angiogenesis and cell proliferation assay.
    Friis T; Kjaer Sørensen B; Engel AM; Rygaard J; Houen G
    APMIS; 2003 Jun; 111(6):658-68. PubMed ID: 12969022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic characterization of a kinetic in vitro human co-culture angiogenesis model using clinically relevant compounds.
    Wolfe A; O'Clair B; Groppi VE; McEwen DP
    J Biomol Screen; 2013 Dec; 18(10):1234-45. PubMed ID: 24019254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells.
    Tamilarasan KP; Kolluru GK; Rajaram M; Indhumathy M; Saranya R; Chatterjee S
    BMC Cell Biol; 2006 Apr; 7():17. PubMed ID: 16584574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.